Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells

Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture

(2010) Zhihua An et al.   CANCER LETTERS

EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance

(2009) M.-L. Suva et al.   CANCER RESEARCH

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

(2009) Evanthia Galanis et al.   JOURNAL OF CLINICAL ONCOLOGY

Epigenetic mechanisms in glioblastoma multiforme

(2009) Raman P. Nagarajan et al.   SEMINARS IN CANCER BIOLOGY

The role of the polycomb complex in silencing  -globin gene expression in nonerythroid cells

(2008) D. Garrick et al.   BLOOD

SpontaneousIn VitroTransformation of Adult Neural Precursors into Stem-Like Cancer Cells

(2008) Florian A. Siebzehnrubl et al.   BRAIN PATHOLOGY

Epigenetic-Mediated Dysfunction of the Bone Morphogenetic Protein Pathway Inhibits Differentiation of Glioblastoma-Initiating Cells

(2008) Jeongwu Lee et al.   CANCER CELL

Promoter hypomethylation regulates CD133 expression in human gliomas

(2008) Kouichi Tabu et al.   CELL RESEARCH

Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

(2008) F. Zeppernick et al.   CLINICAL CANCER RESEARCH

Roles of the EZH2 histone methyltransferase in cancer epigenetics

(2008) Jeffrey A. Simon et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

(2008) Ittai Ben-Porath et al.   NATURE GENETICS

Differentiation of Neural Stem Cells into Oligodendrocytes: Involvement of the Polycomb Group Protein Ezh2

(2008) Falak Sher et al.   STEM CELLS

Cancer stem cells and glioma

(2008) Sunit Das et al.   Nature clinical practice. Neurology